NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/31/2025
Back to search
Official data from USPTO
MOLECULAR HEALTH MH GUIDE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
01/31/2025
Trademark type
Combined
Nice classes
9, 38, 42, 44
Filing date
05/24/2016
Registration date
09/18/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/31/2025
Last transaction
01/31/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/03/2016
First use in commerce
06/03/2016
Drawing code
3
Owner type
99
Owner location
Heidelberg, DE
Examiner
HISER, CHARLES
Current location
Historical data usage
Mark description
The mark consists of the words "MOLECULAR HEALTH" above the larger words "MH GUIDE", the "MH" being in stylized lettering consisting of vertical shapes.
Holders and representatives
Holders
Molecular Health GmbH
Representatives
Peter T. Wakiyama Troutman Pepper Hamilton Sanders LLP
Technical classification
Nice Classes
Class 9Class 38Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable computer databases containing information in the fields of medicinehealth caregenomicsbioinformaticspharmaceuticalslife sciences and biotechnology; downloadable computer databases containing medical and health information on humans; downloadable computer software for accessingorganizingindexingrankingintegratinglinkingreferencingsynthesizinginterpreting and analyzing information from databases in the fields of medicinehealth caregenomicspharmaceuticalslife sciences and biotechnology and databases containing medical and health information or records about or relating to humans; downloadable mobile applications for mobile devicesfor accessingorganizingsynthesizingindexingrankingintegratinglinkingreferencinginterpreting and analyzing information from databases in the fields of medicinehealth caregenomicsbioinformaticspharmaceuticalslife sciences and biotechnology and databases containing medical and health information or records about or relating to humans; downloadable mobile applications for accessing databases in the fields of medicinehealth caregenomicsbioinformaticspharmaceuticals and pharmaceutical safetylife sciences and biotechnology
Class 38
Providing access to searchable databases containing medicalpharmaceuticalbiologicalclinical and genomic information and medical and health information and recordsmolecular test results and patient specific data about or relating to humans for scientific research purposes; providing access to online databases containing medicalpharmaceuticalbiologicalclinicalmolecularsequencing and genomic informationdisease informationbiomarker information and medical or health information or records about or relating to humans and patient specific datamolecular test resultsscientific research for medical diagnostic and treatment purposes; providing access to online software and algorithms for retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular datadiseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationrecords or datapatient specific datamolecular test resultsdata from clinical studiesscientific research for medical diagnostic and treatment purposes; providing access to non-downloadable computer software and algorithms for medical diagnostic and treatment purposes
Class 42
Consulting and research services in the fields of health caremedicinelife sciencesbiotechnologypharmaceuticalsbioinformaticslife sciencesgenomics and pharmaceuticals and pharmaceutical safety for scientific research purposes; consulting and research services in the nature of retrievalintegrationcorrelationanalysis and interpretation of genomicsequencingmolecular data and information on diseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical health information patient specific datamolecular test resultsdata from clinical studiesscientific research for purposes of scientificmedical and pharmaceutical research; designing and developing searchable databases containing medicalpharmaceuticalbiologicalclinical and genomic information and medical and health information and recordsmolecular test results and patient specific data about or relating to humans for scientific research purposes; providing temporary use to non-downloadable computer software and algorithms for retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular data and information on diseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationpatient specific datamolecular test resultsdata from clinical studiesscientific research for use by physiciansclinicians and other healthcare professionalslaboratory personnelconsultantsscientists and other researchers for purposes of scientificmedical and pharmaceutical research; providing temporary use to non-downloadable computer software and algorithms for retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular data and information on diseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationpatient specific datamolecular test resultsdata from clinical studiesscientific research for purposes of scientificmedical and pharmaceutical research; providing temporary use to non-downloadable applications for mobile devicessmart phones and tabletsweb applications accessible through the internet providing information in the fields of medicinehealth caregenomicsbioinformaticspharmaceuticalslife sciences and biotechnology for scientific research purposes; data collection services for scientific research purposes in the fields of genomicshealth carepharmaceuticalslife sciencesbioinformaticsbiotechnology and medicine; services for mobile devicessmart phones and tabletsbeing software design; non-downloadable web applications for accessing databases accessible through the internet in the fields of medicinehealth caregenomicsbioinformaticspharmaceuticals and pharmaceutical safetylife sciences and biotechnology; providing temporary use of non-downloadable computer software and algorithms for retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular data and information on diseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationpatient specific datamolecular test resultsdata from clinical studiesscientific research for medical diagnostic and treatment purposes; medical research servicesthe retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular datadiseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationrecords or datapatient specific datamolecular test resultsdata from clinical studiesscientific research for medical diagnostic and treatment purposes
Class 44
Medical consulting servicesthe retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular datadiseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationrecords or datapatient specific datamolecular test resultsdata from clinical studiesscientific research for medical diagnostic and treatment purposes; consulting services in the fields of medical carepharmaceuticals and medicine; providing medical information in the fields of healthhealthcarelife sciencesbiotechnologypharmaceuticals and pharmaceutical safetybioinformaticsgenetic testing for medical purposes; medical consulting services with respect to the treatment and diagnosis of individuals; providing medical information on drug safety and drug compatibility in relation to therapy and the treatment of individuals; medical consulting services in the fields of diagnostics and patient treatment and treatment protocols
Publications
History of USPTO decisions and trademark events.
41 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/31/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/31/2025
E815
TEAS SECTION 8 & 15 RECEIVED
09/13/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/18/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
09/18/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/17/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/16/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/24/2018
IUAF
USE AMENDMENT FILED
07/11/2018
EISU
TEAS STATEMENT OF USE RECEIVED
07/11/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/11/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/21/2018
EX1G
SOU EXTENSION 1 GRANTED
02/20/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/20/2018
NREV
NOTICE OF REVIVAL - E-MAILED
02/05/2018
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
02/05/2018
PETG
PETITION TO REVIVE-GRANTED
02/05/2018
PROA
TEAS PETITION TO REVIVE RECEIVED
02/05/2018
EXT1
SOU EXTENSION 1 FILED
01/11/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/11/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/16/2017
PUBO
PUBLISHED FOR OPPOSITION
05/16/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/26/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/06/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/05/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/05/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/05/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/27/2017
GNRT
NON-FINAL ACTION E-MAILED
03/27/2017
CNRT
NON-FINAL ACTION WRITTEN
03/27/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/16/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/15/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/15/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/15/2016
GNRT
NON-FINAL ACTION E-MAILED
09/15/2016
CNRT
NON-FINAL ACTION WRITTEN
09/15/2016
DOCK
ASSIGNED TO EXAMINER
09/08/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/02/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/01/2016
NWAP
NEW APPLICATION ENTERED
05/27/2016
Continuous trademark protection
Get notified about every new filing that threatens MOLECULAR HEALTH MH GUIDE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.